Case Western Reserve University receives $1.5M grant for oral drug trial to prevent blindness in RP patients

FHS
July 8, 2024
4:25 pm

There’s only one U.S. Food and Drug Administration-approved therapy for an inherited retinal disease, and dozens of retinitis pigmentosa (RP) genes for which no therapy is available.

Patients wants test results now, and radiologists need time to explain. Can they meet in the middle?

One of the hardest parts about getting an X-ray or a CT scan is the wait. Sometimes it takes days, or even weeks, for medical

December 1, 2023

Digital therapeutics firm Akili to sell for $34M

Dive Brief: Dive Insight: Akili was one of a few companies that sought to develop prescription apps, called digital therapeutics, that have received the FDA’s

May 31, 2024

Syncona to buy biotechnology company Freeline Therapeutics

Share this article Freeline leverages its AAV vector and capsid to deliver a functional copy of a therapeutic gene into human liver cells. Credit: crystal

November 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.